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Abstract
Objective. Chiropractors and osteopaths are important professional partners in the management of
axial spondyloarthritis (axSpA). In view of recent advances in diagnosis and treatment, we sought to
understand their current knowledge and working practices.
Methods. A Web-based survey was advertised to chiropractors and osteopaths via the Royal College
of Chiropractors and the Institute of Osteopathy.
Results. Of 382 completed responses [237 chiropractors (62%) and 145 osteopaths (38%)], all were famil-
iar with AS, but only 63 and 25% were familiar with the terms axSpA and non-radiographic axSpA, respec-
tively. Seventy-seven per cent were confident with inflammatory back pain. Respondents routinely asked
about IBD (91%), psoriasis (81%), acute anterior uveitis (49%), peripheral arthritis (71%), genitourinary/gut
infection (56%), enthesitis (30%) and dactylitis (20%). Eighty-seven per cent were aware of the association
between axSpA and HLA-B27. Only 29% recognized that axSpA was common in women. Forty per cent
recommend an X-ray (pelvic in 80%) and, if normal, 27% would recommend MRI of the sacroiliac joints
and whole spine. Forty-four per cent were aware of biologic therapies. Forty-three per cent were confident
with the process of onward referral to rheumatology via the general practitioner (GP). The principal per-
ceived barrier to onward referral was reluctance by the GP to accept their professional opinion.
Conclusion. Overall knowledge of ankylosing spondylitis is good, but the term axSpA is poorly understood.
Specific learning needs include gender preponderance, awareness of acute anterior uveitis and the availability
of biological therapies. There is lack of confidence in the onward referral process to rheumatology via the GP.
Key words: chiropractor, osteopath, axial spondyloarthritis, ankylosing spondylitis, survey, back pain, acute
anterior uveitis
Key messages
. Back pain is a common clinical presentation in both chiropractic and osteopathic practice.
. The wider spectrum of axial spondyloarthritis is poorly understood by both chiropractors and osteopaths.
. Targeted education on the concept of axial spondyloarthritis and recent advances in therapy are warranted.
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Introduction
Axial spondyloarthritis (axSpA) is a chronic inflammatory
arthritis involving the spine and sacroiliac joints. In 2009,
the Assessment of SpondyloArthritis international Society
(ASAS) published the classification criteria for axSpA,
encompassing both AS and non-radiographic axSpA [1].
The prevalence of axSpA in a primary care population in
the UK was found to be 0.3% using ASAS criteria [2].
Diagnosis of axSpA can be difficult, and therefore, it
is important to maintain a high index of suspicion in or-
der to reduce the delay to diagnosis, which currently
stands at 8.5 years in the UK [3]. Typically, symptoms
start in the second or third decade [4], and conse-
quently, patients often endure intolerable symptoms dur-
ing a formative phase of life when they are attempting to
establish careers and relationships. Moreover, people
have described having to fight to get their diagnosis,
which has been upsetting, distressing and disheartening
and resulted in feelings of anger and frustration [5].
Many of these patients suffer from work disability,
with almost one-third of patients unable to work and an
additional 15% reporting changes to their work because
of AS [6]. In the past, the treatment of AS was limited to
NSAIDs, CSs and conventional synthetic DMARDs,
which were often inadequate or ineffective [7]. Since the
early 2000s, the introduction of TNF inhibitors and IL-17
inhibitors has revolutionized treatment and been shown
to improve disease outcomes significantly [8, 9].
Patients with shorter disease duration have also been
shown to have a better response to treatment, and
therefore, early diagnosis is extremely important [10].
Awareness of axSpA among UK medical professionals
in primary and secondary care is variable and often poor
[11, 12]. Some of the reasons contributing to the delayed
diagnosis include difficulty in distinguishing inflammatory
back pain from other types of back pain and lack of
awareness of extra-articular manifestations. Consequently,
patients may not be investigated appropriately or referred
to rheumatologists [3]. The commonest presenting symp-
tom of axSpA is chronic back pain, with many patients
self-referring to an osteopath or chiropractor for advice
and treatment.
Osteopaths take a holistic view of the body structure
and function to treat a variety of medical conditions
based on the principle that the well-being of an individ-
ual depends on the skeleton, muscles, ligaments and
connective tissues functioning smoothly together [13].
They use manual therapy, exercise and health advice to
promote the optimal environment for health [13]. All
osteopaths in the UK are regulated by law through the
General Osteopathic Council and recognized by the
National Health Service (NHS) England as an allied
health profession [13, 14]. They are trained to degree
level and must have a minimum of 1000 patient-contact
hours before qualification. There are currently >5300
osteopaths on the UK Statutory Regulator Register [14].
Chiropractic is a health profession concerned with the
diagnosis and treatment of mechanical disorders of the
musculoskeletal system and the effects of these disor-
ders on the function of the nervous system and the gen-
eral health. They emphasize manual treatments, including
spinal adjustment and other joint and soft tissue manipu-
lation [15]. Chiropractors are trained to a degree level be-
fore registration with the General Chiropractic Council.
Many chiropractors further their studies at Masters level
in areas of special interest, such as sport, and some
undertake professional doctorate or PhD studies. All
chiropractors in the UK are regulated by the General
Chiropractic Council, and there are currently 3239 chiro-
practors registered on the statutory Chiropractic Register
in the UK [16].
A UK study has identified that 30% of newly diagnosed
axSpA patients have seen either an osteopath or a chiro-
practor before diagnosis [17]; therefore, it is essential that
these important groups of regulated health-care profes-
sionals have a comprehensive understanding of the con-
dition in order to identify the symptoms and signs early
and direct referral to rheumatology in order to establish a
diagnosis and provide effective therapy.
In this survey, we sought to understand current
knowledge of axSpA and working practices of chiro-
practors and osteopaths working in the UK.
Methods
The survey comprised 30 open and closed questions re-
lating to the background of the health professionals, dis-
ease terminology, symptoms recognition, clinical
features, investigations, treatment, and the onward re-
ferral process to rheumatologists via general practi-
tioners (GPs). This survey materials were developed by
the study team, who have the following professional
backgrounds; rheumatology (3), osteopathy (2) and chi-
ropractic (2). This study did not require ethical approval.
The first question on the survey was, ‘Are you a prac-
tising osteopath or chiropractor?’, in order to verify the
professional identity of the respondent. The survey was
administered by survey monkey and advertised to pro-
fessional members via the Royal College of
Chiropractors and Institute of Osteopathy using online
mechanisms including e-news and promotion by social
media for a period of 5 weeks in June and July 2018.
The Institute of Osteopathy is the professional body
representing osteopaths in the UK, and it represents
>70% of UK registered osteopaths [18]. The Royal
College of Chiropractors is an apolitical professional
membership body representing chiropractors and cur-
rently has >1500 UK members [19].
Results
Demographics
Three hundred and eighty-two completed responses
were received within 1 month; 237 chiropractors (62%)
and 145 osteopaths (38%). The demographics of the
responders were 59% female, 81% between 30 and
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59 years of age, and 63% practicing for >10 years. There
was a wide geographical spread, with the largest propor-
tions from the south west (22%) and south east (21%).
Thirty-eight per cent of respondents worked as sole practi-
tioners, 30% in group practice, and 32% in a multidiscipli-
nary clinic. Seventy-two per cent reported that between
20 and 60% of their patients presented with chronic back
pain. A majority (59%) saw between 1 and 5 patients with
chronic back pain per day, and 30% between 6 and 15.
Terminology
Regarding disease terminology, all respondents were fa-
miliar with the term AS, and 99% were confident with
their understanding, 63% were familiar and 57% confi-
dent with their understanding of axSpA, and 25% were
familiar and 22% confident with their understanding of
non-radiographic axSpA.
Symptom recognition
Seventy-seven per cent were confident with the concept
of inflammatory back pain, 19% somewhat confident,
and 4% not confident. The results for awareness of indi-
vidual features of inflammatory back pain are outlined in
Table 1. Fifty-two per cent would also consider localized
spinal tenderness as important, and 16% radicular pain.
Regarding extra-articular manifestations and peripheral
musculoskeletal manifestations, the proportion of
respondents who would routinely ask about or examine
for the features are shown in Table 2. In addition, 79%
routinely asked about a family history of SpA.
Twenty-nine per cent recognized that axSpA was
common in women, and 87% were aware of the associ-
ation between axSpA and HLA-B27. Thirty-three per
cent knew that >60% of patients are HLA-B27 positive,
and 38% were unsure.
Investigations
Fifty-six per cent would enquire about inflammatory
markers (ESR or CRP), and 67% would not exclude
axSpA if the markers were normal. Forty per cent would
recommend an X-ray for patients with suspected
axSpA; 80% pelvic, 71% lumbar spine, 38% thoracic
spine and 27% cervical. If the X-ray was normal, 50%
would recommend an MRI of the lumbar spine and sa-
croiliac joints; 27% whole spine and sacroiliac joints;
10% CT of the lumbar spine and sacroiliac joints; 10%
isotope bone scan; and 10% US of the sacroiliac joints.
Treatment
Forty-four per cent of respondents were aware of the
availability of biologic therapies to treat axSpA. The
most common themes that emerged from the open
question regarding any specific need to improve confi-
dence in treating axSpA were as follows: more in-depth
knowledge on treatment; more information on signpost-
ing; more up-to-date knowledge on the latest develop-
ments; and help with forging better relationships with
GPs to ease the issues with the referral pathway.
Referral
On a weighted average scale, respondents indicated a
confidence level of 3.2 out of 5 with the onward referral
via GPs; 43% were either confident or very confident.
Sixty-one per cent routinely checked the outcomes of
their recommendation for onward referral; 87% with the
patient, 12% with the GP, and 1% with both. An open
question asked respondents to comment on barriers to
recommending onward referral, with the most common
being a reluctance by GPs to accept findings and rec-
ommendations from chiropractors and osteopaths, in
addition to a general unwillingness by GPs to refer to
secondary care. Some commented on their own lack of
confidence in their recommendation letters, whereas
others found no barriers and saw development of a
good relationship and strong communications with the
local GPs as fundamental to the acceptance of any rec-
ommendations. Seventy-eight per cent were familiar
with the National Ankylosing Spondylitis Society (NASS)
TABLE 1 Proportion of respondents who identified various
symptoms of inflammatory back pain
Symptom Number of
respondents
from 317
responses
Proportion (%)
of respondents
Morning stiffness
>30 min
263 83
Symptom duration
>3 months
256 80
Insidious onset 249 78
Pain relieved by NSAID 244 77
Pain at night 208 66
Pain relieved by activity 174 55
Pain aggravated by rest 158 50
Alternating buttock pain 111 35
TABLE 2 Proportion who enquire/examine for the pres-
ence of extra-articular manifestations and peripheral mus-
culoskeletal manifestations
Symptom Number of
respondents
from 312
responses
Proportion (%)
of respondents
IBD 284 91
Psoriasis 254 81
Genitourinary/
gut infection
174 56
Acute anterior
uveitis
152 49
Enthesitis 93 30
Dactylitis 61 20
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and 35% referred their patients to NASS for information
on axSpA.
Discussion
This survey shows that back pain is a common clinical
presentation in both chiropractic and osteopathic prac-
tice. The concept of AS is well recognized and under-
stood, but the terms axSpA and non-radiographic
axSpA are less well known. This is compatible with a
survey of patients and rheumatologists, in which only
44% of patients were aware of the term axSpA and
88% of rheumatologists accepted the term axSpA [20].
There is a belief that axSpA affects only men.
Historically, AS was seen as a predominantly male dis-
ease. However, more recent data have shown that
axSpA has an equal male-to-female preponderance
[1, 21], meaning that it is important to consider this di-
agnosis in women.
Recognition of the concept and typical characteristics
of inflammatory back pain is good except for alternating
buttock pain, which was recognized by only 35% of
respondents. This was similar to a GP survey under-
taken in 2008 [12]. Awareness of extra-articular manifes-
tations is also good, but acute anterior uveitis was
recognized by only 49% despite the fact that it is the
commonest extra-articular manifestation, with a preva-
lence of 26% [22]. In a previous survey of GPs, acute
anterior uveitis was also the least recognized extra-
articular manifestation, meaning that targeted education
of health-care professionals on this important extra-
articular manifestation is warranted. Recent studies have
shown that screening for chronic back pain among
patients with acute anterior uveitis could potentially be
used as a targeted strategy for the identification of
undiagnosed axSpA and shortening the delay to diagno-
sis [23, 24]. There is also a lack of awareness about the
availability of biological therapies. These findings all sup-
port the need to update chiropractors and osteopaths
on aspects of axSpA.
General practitioners are the gatekeepers for onward
referral to rheumatology for diagnosis and long-term
management of axSpA. It has previously been shown
that there is often a delay between patients presenting
to their GP and subsequent onward referral and diagno-
sis [25]. In our study, we identified that both chiroprac-
tors and osteopaths perceive that there is a barrier to
onward referral to rheumatologists and that GPs seem
reluctant to accept the findings and recommendations
of chiropractors and osteopaths. Given the significant
delay in the diagnosis of axSpA [3], these barriers need
to be overcome, especially given that earlier diagnosis
and initiation of therapy translates into better clinical
outcomes [26].
This paper has a number of limitations. Firstly, we ac-
knowledge that we have a relatively small sample size,
although there was a wide geographical distribution.
Secondly, the responses we received will have been
from professionals who are interested in engaging,
which might introduce a bias. There is also a potential
for recall bias, especially in relationship to situations
where there has been a perceived barrier to onward re-
ferral. Nonetheless, we consider that these data provide
important clinical information that is highly relevant to
the diagnosis and optimal management of axSpA
patients in the UK.
As a consequence of this survey, NASS has devel-
oped the NASS Allies programme in collaboration with
the Royal College of Chiropractors and Institute of
Osteopathy [27]. A referral template letter has been de-
veloped and endorsed by both the Royal College of
General Practitioners and the Chartered Society of
Physiotherapy in order to facilitate onward referral to
rheumatology via the GP. This template was launched at
the Primary Care and Public Health Conference 2019 on
15 May 2019 [27]. In addition, in order to educate osteo-
paths and chiropractors, a programme of seminars will
be held throughout the UK during 2019–20, and a webi-
nar will be developed.
We recommend that targeted education and training
on axSpA be delivered to osteopaths and chiropractors
as part of undergraduate and postgraduate training
programmes.
Conclusion
AS, but not the wider spectrum of axSpA, is well under-
stood by both chiropractors and osteopaths. The most
striking findings were as follows: a belief that axSpA is a
disease of men; poor recognition of acute anterior uve-
itis as an extra-articular manifestation; and the lack of
awareness about the availability of biological therapies.
Targeted education on the concept and recent advan-
ces in axSpA is warranted. The poor acceptance of
osteopaths’ and chiropractors’ clinical assessment by
GPs was strongly reflected in the lack of confidence
around recommending onward referral.
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